Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
Guardant Health logo

Guardant Health Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Guardant Health holds $1.9B in total assets. Shareholders' equity is -$181.1M against $1.7B in total debt. Cash and equivalents total $1.1B. The current ratio is 4.68 and debt-to-equity is -9.41. Based on the Q1 2026 filing.

Total Assets$1.9BTotal Stockholders Equity-$181.1MLong Term Debt$1.5BCash And Equivalents$1.1BTotal Current Assets$1.4BTotal Current Liabilities$292.1M
Latest FilingQ1 2026
Report Date2026-05-07
Market Cap$17.2B
ROE200.62%

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$110.3M$115.4M$130.3M$115.6M$137.8M$137.4M
Available-for-Sale Debt Securities - Amortized Cost————$1.3B$1.1B
Cash and cash equivalents$629.8M$803.9M$735.5M$689.5M$489.4M$1.1B
Cash, Cash Equivalents, and Marketable Securities————$1.3B$1.1B
Available For Sale Securities Debt Securities Current$314.4M$0$0$0$823.4M$113.5M
Inventories$71.1M$77.3M$84.1M$90.5M$85.9M$83.9M
Prepaid expenses and other current assets$33.8M$35.8M$40M$42.8M$40.7M$43.5M
Restricted cash$104.2M$105.3M$106.3M$109.5M$111.2M$112.2M
Short-term investments$314.4M$0$0$0$823.4M$113.5M
Total current assets$1.1B$927M$883.4M$828.9M$1.5B$1.4B

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accrued compensation$83.2M$63.7M$68.3M$98.2M$119.6M$91.3M
Accrued expenses$68.3M$76M$71M$71.7M$77.9M$78M
Accrued Progress Collections and Price Adjustments$6.1M$7.7M$6.4M$9.5M$9M$8.9M
Other Commercial Liabilities$68.3M$76M$71M$71.7M$77.9M$78M
Contract liabilities$6.1M$7.7M$6.4M$9.5M$9M$8.9M
Accrued Liabilities, Current$68.3M$76M$71M$71.7M$77.9M$78M
Deferred revenue$35.5M$36.3M$54.4M$46.9M$50.8M$47.8M
Lease Liability Payments - 2020 (Remaining Three Months)—$27.8M$16.6M$7.4M—$25.6M
Operating Lease Liability Payments - 2024 (Lessee)—$27.5M$35.4M$35.3M—$35.7M
Operating Lease Liability Payments - 2025 (Lessee)—$22.9M$34.4M$34.4M—$34.8M
Lease Liability Payments - Due Year Two—$27.5M$35.4M$35.3M—$35.7M
Lease Liability Payments - Due Year Three—$24.5M$35.2M$35.2M—$34.6M
Lease Liability Payments - Due Year Four—$22.9M$34.4M$34.4M—$34.8M
Lease Liability Payments - Remainder of Fiscal Year—$31.6M$34.4M$34.4M—$35.9M
Operating lease liabilities, current$29.2M$29.7M$26.3M$26.4M$27.7M$28M
Operating Lease Liability Payments Due—$215.2M$254.9M$245.7M—$230.6M
Operating Lease Liability - Undiscounted Excess Amount—$25.2M$36.3M$33.9M—$29.5M
Total current liabilities$225.6M$225.8M$238.4M$236.9M$302.7M$292.1M

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accumulated Goodwill Impairment Losses—$0$0$0—$0
Deferred Tax Assets and Other Non-Current Assets$37.2M$32.6M$37.2M$41.5M$28.5M$28.9M
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)—$765K$765K$765K—$600K
Finite Lived Intangible Assets - Gross$18.6M$17M$17M$17M$17M$17M
Goodwill$3.3M$3.3M$3.3M$3.3M$77.3M$77.3M
Goodwill and Intangible Assets, Net$10.1M$9.6M$9.2M$8.8M$103.2M$102.8M
Equity securities$16.1M$11.1M$16.1M$20.1M$6.5M$6.5M
Intangible assets, net$6.8M$6.3M$5.9M$5.5M$5.1M$4.7M
Investments - Amortized Cost Basis————$1.3B$1.1B
Net Investment in Lease$142.3M$140.5M$169.8M$163.6M$158.8M$153.9M
Intangible assets — net$6.8M$6.3M$5.9M$5.5M$5.1M$4.7M
Other intangible assets—net$6.8M$6.3M$5.9M$5.5M$25.9M$25.5M
Goodwill and intangible assets, net$10.1M$9.6M$9.2M$8.8M$103.2M$102.8M
Operating lease right-of-use assets$142.3M$140.5M$169.8M$163.6M$158.8M$153.9M
Other non-current assets$37.2M$32.6M$37.2M$41.5M$28.5M$28.9M
Property, plant and equipment at cost$302.3M$304.6M$311.1M$315.9M$344.8M$355M
Operating lease right-of-use assets14226500000.0%3.8%4.5%4.5%4.5%4.5%
Operating Lease Right-of-Use Assets in Other Assets$142.3M$140.5M$169.8M$163.6M$158.8M$153.9M
Other non-current assets$37.2M$32.6M$37.2M$41.5M$28.5M$28.9M
Accumulated depreciation$165.5M$175.3M$184.9M$191.3M$198.9M$205M
Property and equipment, net$136.8M$129.3M$126.1M$124.6M$145.9M$150M
Software and Technology Licenses, Net$37.2M$32.6M$37.2M$41.5M$28.5M$28.9M
Total assets$1.5B$1.3B$1.3B$1.3B$2B$1.9B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Additional paid-in capital$2.4B$2.5B$2.5B$2.6B$2.9B$2.9B
Accumulated other comprehensive income (loss)-$5.2M-$4.7M-$3.7M-$4.3M-$4.9M-$5.2M
Common stock$1K$1K$1K$1K$1K$1K
Common Stock Par Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Common Stock Shares Issued124M124.6M125.5M126M130.6M131.5M
Common Stock Shares Outstanding$36M$75.1M$113.9M$158.1M$310.5M$261.1M
Convertible Preferred Stock Authorized Shares10M10M10M10M10M10M
Convertible Preferred Stock Issued Shares000000
Convertible Preferred Stock Outstanding Shares000000
Cumulative Gross Losses and Impairments—$0$0$0—$0
Number of Exercisable Options—2.6M2.8M2.8M—3M
Preferred stock$0$0$0$0$0$0
Preferred Stock Par Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Retained earnings-$2.6B-$2.7B-$2.8B-$2.9B-$3B-$3.1B
Share-Based Payment Award Options Outstanding - Number4.6M5.1M5.1M5M4.5M4.4M
Share-Based Payment - Unrecognized Cost of Nonvested Awards—$48.8M$43.7M$37.4M—$25.6M
Shares Reserved for Future Issuance Under Stock Plans27.1M31.3M30.5M30M28.2M32.1M
Total liabilities and stockholders' equity$1.5B$1.3B$1.3B$1.3B$2B$1.9B
Total stockholders' equity-$139.6M-$250.8M-$305.5M-$354.5M-$99.3M-$181.1M
Unrealized Gains on Investments$232K$3K$0$0$130K$0
Unrealized Losses on Investments (Before Tax)$0$1K$0$4K$40K$16K
Weighted Average Exercise Price of Outstanding Options$32.98$34.15$34.47$34.65$34.83$34.94

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Contract Liabilities, Non-Current$6.1M$7.7M$6.4M$9.5M$9M$8.9M
Convertible Debt (Non-Current)$1.1B$1.1B$1.1B$1.1B$1.5B$1.5B
Operating Lease Liability Payments - 2027 (Lessee)—$24.5M$35.2M$35.2M—$34.6M
Operating Lease Liability Payments - 2028 (Lessee)—$22.9M$34.4M$34.4M—$34.8M
Long-term debt$1.1B$1.1B$1.1B$1.1B$1.5B$1.5B
Deferred revenue, net of current portion$6.1M$7.7M$6.4M$9.5M$9M$8.9M
Operating lease liabilities, non-current$164.3M$160.4M$192.3M$185.4M$178.5M$173.1M
Operating Lease Liabilities (Total)$193.5M$190M$218.6M$211.8M$206.1M$201.1M
Other non-current liabilities$92.8M$92.5M$91.2M$94.4M$127.8M$127.7M
Total liabilities$1.6B$1.6B$1.6B$1.6B$2.1B$2.1B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Cumulative Cost Basis$302.3M$304.6M$311.1M$315.9M$1.3B$1.1B
Number of Class Action Lawsuits——$2$2—$2
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax$0$1K$0$4K$40K$16K
Gross Unrealized Gains$232K$3K$0$0$130K$0
Total————$1.3B$1.1B
Available for sale investments————$1.3B$1.1B
Common stock, capital shares reserved for future issuance$27.1M$31.3M$30.5M$30M$28.2M$32.1M
Common stock, par value (in dollars per share)$0$0$0$0$0$0
Common stock, shares authorized (in shares)$350M$350M$350M$350M$350M$350M
Common stock, shares issued (in shares)$124M$124.6M$125.5M$126M$130.6M$131.5M
Common Stock, Shares, Outstanding$124M$123.6M$124.5M$125M$130.6M$131.5M
Contract with Customer, Asset, after Allowance for Credit Loss$3.4M$4.2M$3.8M$5.1M$5.2M$6.2M
Contract with Customer, Liability$41.6M$44M$60.7M$56.4M$59.7M$56.7M
Convertible debentures$1.1B$1.1B$1.1B$1.1B$1.5B$1.5B
Cost not yet recognized—$48.8M$43.7M$37.4M—$25.6M
2031 and thereafter—$897K$897K$897K—$297K
Finite-Lived Intangible Assets, Accumulated Amortization$11.8M$10.7M$11.1M$11.5M$11.9M$12.3M
2028—$1.1M$1.1M$1.1M—$1.1M
2030—$765K$765K$765K—$600K
Remainder of 2026—$1.2M$774K$387K—$834K
2027—$1.2M$1.2M$1.2M—$1.1M
2029—$1.1M$1.1M$1.1M—$765K
Gross Carrying Amount$18.6M$17M$17M$17M$17M$17M
Goodwill accumulated impairment losses—$0$0$0—$0
Indefinite-Lived Intangible Assets (Including Goodwill)————$98.1M$98.1M
Intangible Assets, Gross (Including Goodwill)$21.9M$20.3M$20.3M$20.3M$115.1M$115.1M
Lessee Operating Lease Liability Payments Due—$215.2M$254.9M$245.7M—$230.6M
2031 and thereafter—$80.8M$99M$99M—$64.1M
Lessee Operating Lease Liability Undiscounted Excess Amount—$25.2M$36.3M$33.9M—$29.5M
Area of square feet leased——163000.00———
Number of class action complaints——$2$2—$2
Number of lawsuits with an additional claim——1.001.00—1.00
Number of investees deemed variable interest entity, not primary beneficiary———1.00—1.00
Number of revenue sources—4.004.004.00—4.00
Incremental borrowing rate——8.0%———
Operating Lease Weighted Average Discount Rate Percent$0$0$0$0$0$0
Other accrued liabilities$39.1M$46.3M$44.7M$45.3M$50.2M$50M
Preferred Stock, Par or Stated Value Per Share$0$0$0$0$0$0
Preferred Stock, Shares Authorized$10M$10M$10M$10M$10M$10M
Preferred Stock, Shares Issued$0$0$0$0$0$0
Preferred Stock, Shares Outstanding$0$0$0$0$0$0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number$4.6M$5.1M$5.1M$5M$4.5M$4.4M
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price$33$34.2$34.5$34.7$34.8$34.9
Incentive stock program, shares reserved for future grants (in shares)$12M$13.2M$13.2M$13.1M$13.2M$14.9M
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value$36M$75.1M$113.9M$158.1M$310.5M$261.1M
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price—$34.4$34.8$35—$34.2
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value—$50M$71.1M$96.7M—$180.9M
Shares Issued Price Per Share————$90.00—
Remainder of Fiscal Year 2024—$27.8M$16.6M$7.4M—$25.6M
Remainder of Fiscal Year 2025—$1.2M$774K$387K—$834K